AXSM
Axsome Therapeutics, Inc.
Latest Form 4:Sale$9.5MbyTABUTEAU HERRIOT (Chief Executive Officer) · filed Aug 7, 2026
Axsome Therapeutics, Inc. (AXSM) has 31 SEC Form 4 filings (86 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Aug 7, 2026.
The most active filer is Chief Executive Officer TABUTEAU HERRIOT with 20 filings. Insiders have net sold $59.0M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Herriot Tabuteau
- Employees:1,346
- HQ:New York City, NY, US
- IPO:2015-11-19
Insider Buying
$200K
reported purchases (SEC code P)
Insider Selling
$154.2M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Market Cap
$10.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 45,004 | $9.5M | Aug 7 | SEC ↗ | |
| Chief Executive Officer | Sale | 4,660 | $997K | Aug 7 | SEC ↗ | |
| Chief Executive Officer | Sale | 49,666 | $11.9M | Jul 1 | SEC ↗ | |
| Director | Sale | 286 | $70K | Jun 12 | SEC ↗ | |
| Director | Sale | 286 | $71K | Jun 12 | SEC ↗ | |
Mahony SusanFirst filing | Director | Sale | 300 | $71K | Jun 11 | SEC ↗ |
Mahony SusanFirst filing | Director | Sale | 300 | $74K | Jun 11 | SEC ↗ |
| Director | Sale | 643 | $160K | Jun 11 | SEC ↗ | |
TABUTEAU HERRIOTFirst in 4 months | Chief Executive Officer | Sale | 49,670 | $12.0M | Jun 9 | SEC ↗ |
Pizzie NickFirst in 5 months | Chief Financial Officer | Sale | 33,000 | $7.9M | Jun 9 | SEC ↗ |
Coleman MarkFirst in 3 months | Director | Sale | 6,000 | $1.4M | Jun 2 | SEC ↗ |
Coleman MarkFirst in 3 months | Director | Sale | 6,000 | $1.4M | Jun 2 | SEC ↗ |
Coleman MarkFirst in 3 months | Director | Sale | 5,537 | $1.2M | Jun 2 | SEC ↗ |
| Chief Operating Officer | Sale | 4,517 | $1.0M | May 6 | SEC ↗ | |
| Chief Operating Officer | Sale | 233 | $53K | May 6 | SEC ↗ | |
Maizel AriFirst in 3 months | Chief Commercial Officer | Sale | 7,500 | $1.4M | Apr 23 | SEC ↗ |
Jacobson Mark L.First in 5 months | Chief Operating Officer | Sale | 35,378 | $5.7M | Feb 27 | SEC ↗ |
Coleman MarkFirst in 6 months | Director | Sale | 25,000 | $4.0M | Feb 27 | SEC ↗ |
| Chief Executive Officer | Sale | 32,410 | $6.0M | Feb 2 | SEC ↗ | |
Maizel AriFirst filing | Chief Commercial Officer | Sale | 7,500 | $1.4M | Jan 23 | SEC ↗ |
Pizzie NickFirst filing | Chief Financial Officer | Sale | 12,000 | $2.3M | Jan 23 | SEC ↗ |
| Chief Executive Officer | Sale | 78,703 | $13.5M | Jan 7 | SEC ↗ | |
| Chief Executive Officer | Sale | 29,450 | $5.1M | Jan 7 | SEC ↗ | |
| Chief Executive Officer | Sale | 31,261 | $5.3M | Jan 7 | SEC ↗ | |
Saad Mark EFirst in 4 months | Director | Sale | 37,577 | $6.2M | Jan 2 | SEC ↗ |
| Chief Executive Officer | Sale | 49,252 | $7.1M | Dec 4 | SEC ↗ | |
| Chief Executive Officer | Sale | 20,163 | $3.0M | Dec 4 | SEC ↗ | |
| Chief Executive Officer | Sale | 10,558 | $1.6M | Dec 4 | SEC ↗ | |
| Chief Executive Officer | Sale | 91,705 | $12.1M | Nov 5 | SEC ↗ | |
| Chief Executive Officer | Sale | 50,459 | $6.8M | Nov 5 | SEC ↗ | |
| Chief Executive Officer | Sale | 21,775 | $2.9M | Nov 5 | SEC ↗ | |
| Chief Executive Officer | Sale | 19,220 | $2.3M | Oct 8 | SEC ↗ | |
| Chief Executive Officer | Sale | 13,390 | $1.6M | Oct 8 | SEC ↗ | |
| Chief Executive Officer | Sale | 12,774 | $1.5M | Oct 8 | SEC ↗ | |
| Chief Operating Officer | Sale | 10,000 | $1.2M | Sep 22 | SEC ↗ | |
Jacobson Mark L.First filing | Chief Operating Officer | Sale | 45,783 | $5.2M | Sep 17 | SEC ↗ |
TABUTEAU HERRIOTFirst filing | Chief Executive Officer | Sale | 27,907 | $3.3M | Sep 16 | SEC ↗ |
TABUTEAU HERRIOTFirst filing | Chief Executive Officer | Sale | 15,254 | $1.8M | Sep 16 | SEC ↗ |
TABUTEAU HERRIOTFirst filing | Chief Executive Officer | Sale | 19,719 | $2.3M | Sep 16 | SEC ↗ |
Coleman MarkFirst filing | Director | Purchase | 1,575 | $200K | Sep 9 | SEC ↗ |
Saad Mark EFirst filing | Director | Sale | 9,127 | $1.1M | Sep 5 | SEC ↗ |
JEFFS ROGERFirst filing | Director | Sale | 13,464 | $1.7M | Sep 2 | SEC ↗ |
Related companies
Axsome Therapeutics, Inc. is in the Healthcare sector.